These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

258 related items for PubMed ID: 20463004

  • 1. Furanocoumarin derivatives in Kampo extract medicines inhibit cytochrome P450 3A4 and P-glycoprotein.
    Iwanaga K, Hayashi M, Hamahata Y, Miyazaki M, Shibano M, Taniguchi M, Baba K, Kakemi M.
    Drug Metab Dispos; 2010 Aug; 38(8):1286-94. PubMed ID: 20463004
    [Abstract] [Full Text] [Related]

  • 2. Inhibitory effects of furanocoumarin derivatives in Kampo extract medicines on P-glycoprotein at the blood-brain barrier.
    Iwanaga K, Yoneda S, Hamahata Y, Miyazaki M, Shibano M, Taniguchi M, Baba K, Kakemi M.
    Biol Pharm Bull; 2011 Aug; 34(8):1246-51. PubMed ID: 21804213
    [Abstract] [Full Text] [Related]

  • 3. Effects of furanocoumarins in Kampo extract-based medicines on rat intestinal absorption of CYP3A and P-glycoprotein substrate drugs in vivo.
    Iwanaga K, Arimune K, Miyazaki M, Shibano M, Taniguchi M, Baba K, Kakemi M.
    Arch Pharm Res; 2012 Jun; 35(6):1055-64. PubMed ID: 22870815
    [Abstract] [Full Text] [Related]

  • 4. Effect of furanocoumarin derivatives in grapefruit juice on the uptake of vinblastine by Caco-2 cells and on the activity of cytochrome P450 3A4.
    Ohnishi A, Matsuo H, Yamada S, Takanaga H, Morimoto S, Shoyama Y, Ohtani H, Sawada Y.
    Br J Pharmacol; 2000 Jul; 130(6):1369-77. PubMed ID: 10903978
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Selective inhibition of human cytochrome P450 3A4 by N-[2(R)-hydroxy-1(S)-indanyl]-5-[2(S)-(1, 1-dimethylethylaminocarbonyl)-4-[(furo[2, 3-b]pyridin-5-yl)methyl]piperazin-1-yl]-4(S)-hydroxy-2(R)-phenylmethy lpentanamide and P-glycoprotein by valspodar in gene transfectant systems.
    Kawahara I, Kato Y, Suzuki H, Achira M, Ito K, Crespi CL, Sugiyama Y.
    Drug Metab Dispos; 2000 Oct; 28(10):1238-43. PubMed ID: 10997946
    [Abstract] [Full Text] [Related]

  • 7. Potent in vitro inhibition of CYP3A4 and P-glycoprotein by Rhodiola rosea.
    Hellum BH, Tosse A, Hoybakk K, Thomsen M, Rohloff J, Georg Nilsen O.
    Planta Med; 2010 Mar; 76(4):331-8. PubMed ID: 19790032
    [Abstract] [Full Text] [Related]

  • 8. The consequence of regional gradients of P-gp and CYP3A4 for drug-drug interactions by P-gp inhibitors and the P-gp/CYP3A4 interplay in the human intestine ex vivo.
    Li M, de Graaf IA, van de Steeg E, de Jager MH, Groothuis GM.
    Toxicol In Vitro; 2017 Apr; 40():26-33. PubMed ID: 27939799
    [Abstract] [Full Text] [Related]

  • 9. Inhibitory effects of CYP3A4 substrates and their metabolites on P-glycoprotein-mediated transport.
    Katoh M, Nakajima M, Yamazaki H, Yokoi T.
    Eur J Pharm Sci; 2001 Feb; 12(4):505-13. PubMed ID: 11231118
    [Abstract] [Full Text] [Related]

  • 10. In vitro inhibition of CYP3A4 metabolism and P-glycoprotein-mediated transport by trade herbal products.
    Hellum BH, Nilsen OG.
    Basic Clin Pharmacol Toxicol; 2008 May; 102(5):466-75. PubMed ID: 18331390
    [Abstract] [Full Text] [Related]

  • 11. Inhibition of cytochrome P450 by furanocoumarins in grapefruit juice and herbal medicines.
    Guo LQ, Yamazoe Y.
    Acta Pharmacol Sin; 2004 Feb; 25(2):129-36. PubMed ID: 14769198
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of the CYP3A4-mediated metabolism and P-glycoprotein-mediated transport of the HIV-1 protease inhibitor saquinavir by grapefruit juice components.
    Eagling VA, Profit L, Back DJ.
    Br J Clin Pharmacol; 1999 Oct; 48(4):543-52. PubMed ID: 10583025
    [Abstract] [Full Text] [Related]

  • 13. P-glycoprotein and cytochrome P450 3A act together in restricting the oral bioavailability of paclitaxel.
    Hendrikx JJ, Lagas JS, Rosing H, Schellens JH, Beijnen JH, Schinkel AH.
    Int J Cancer; 2013 May 15; 132(10):2439-47. PubMed ID: 23090875
    [Abstract] [Full Text] [Related]

  • 14. In vitro interaction of the HIV protease inhibitor ritonavir with herbal constituents: changes in P-gp and CYP3A4 activity.
    Patel J, Buddha B, Dey S, Pal D, Mitra AK.
    Am J Ther; 2004 May 15; 11(4):262-77. PubMed ID: 15266218
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Grapefruit juice-drug interactions: Grapefruit juice and its components inhibit P-glycoprotein (ABCB1) mediated transport of talinolol in Caco-2 cells.
    de Castro WV, Mertens-Talcott S, Derendorf H, Butterweck V.
    J Pharm Sci; 2007 Oct 15; 96(10):2808-17. PubMed ID: 17542018
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Inhibitory potencies of 1,4-dihydropyridine calcium antagonists to P-glycoprotein-mediated transport: comparison with the effects on CYP3A4.
    Katoh M, Nakajima M, Yamazaki H, Yokoi T.
    Pharm Res; 2000 Oct 15; 17(10):1189-97. PubMed ID: 11145223
    [Abstract] [Full Text] [Related]

  • 19. Comparative studies to determine the selective inhibitors for P-glycoprotein and cytochrome P4503A4.
    Achira M, Suzuki H, Ito K, Sugiyama Y.
    AAPS PharmSci; 1999 Oct 15; 1(4):E18. PubMed ID: 11741214
    [Abstract] [Full Text] [Related]

  • 20. Effects of Kampo medicines on CYP and P-gp activity in vitro.
    Ito K, Satoh T, Watanabe Y, Ikarashi N, Asano T, Morita T, Sugiyama K.
    Biol Pharm Bull; 2008 May 15; 31(5):893-6. PubMed ID: 18451514
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.